Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

New

CTTQ aim to become the pacesetter in the Chinese pharmaceutical industry. We are innovation driven, and focus on R & D to develop new technologies and patented products to improve quality of life and promote human health. At present, we manufacture over 50 prescription medicines in 5 core therapeutic areas, including liver diseases, oncology, respiratory diseases, antibiotics and diabetes.CTTQ maintains 20+% annual revenue growth in every of the past 6 years, and its total sales reached 15.2 billion RMB in 2016. Our APIs and FDFs are sold to all major continents including Americas, Europe, Asia, and Africa.

 

 

Location: 
C26

Contact details

China